» Articles » PMID: 8835747

Stimulation of Bile Acid 6 Alpha-hydroxylation by Rifampin

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 1996 Jun 1
PMID 8835747
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rifampin was shown to relieve pruritus in cholestatic liver diseases. There has been much speculation about the origin of pruritus, but it has not yet been comprehensively explained. The role of bile acids in producing pruritus is obscure and still under debate. Since rifampin both inhibits the uptake of bile acids into the hepatocyte and strongly induces mixed-function oxidases in the liver, the beneficial effects of this drug might be a consequence of altered bile acid metabolism.

Methods: We investigated the influence of rifampin on urinary bile acid excretion with special respect to glucuronide and sulphate conjugates in 14 healthy volunteers before and after administration of rifampin, 600 mg x 7 days, using each subject as his or her own control.

Results: Bile acid glucuronide excretion increased from 0.55 to 1.19 mumol/24 h. This was in particular due to a significant increase of the urinary excretion of the 6 alpha-hydroxylated hyocholic and hyodeoxycholic acids, the relative amounts of which accounted for about two thirds of the urinary bile acid excretion. Excretion of sulphates, however, decreased from 1.40 to 0.86 mumol/24 h due to a significantly reduced excretion of lithocholic acid sulphate. No changes in the excretion rates of other primary and secondary bile acids and no changes in their conjugation patterns were observed.

Conclusions: The results provide evidence that rifampin induces 6 alpha-hydroxylation of bile acids. The products are subsequently glucuronidated at the 6 alpha-hydroxy group, thus stimulating renal excretion of potentially toxic bile acids.

Citing Articles

Efficient stereoselective hydroxylation of deoxycholic acid by the robust whole-cell cytochrome P450 CYP107D1 biocatalyst.

Sun C, Hu B, Li Y, Wu Z, Zhou J, Li J Synth Syst Biotechnol. 2023; 8(4):741-748.

PMID: 38107826 PMC: 10722395. DOI: 10.1016/j.synbio.2023.11.008.


Clinicopathologic Features, Genetics, Treatment, and Long-Term Outcomes in Japanese Children and Young Adults with Benign Recurrent Intrahepatic Cholestasis: A Multicenter Study.

Kato K, Umetsu S, Togawa T, Ito K, Kawabata T, Arinaga-Hino T J Clin Med. 2023; 12(18).

PMID: 37762919 PMC: 10532077. DOI: 10.3390/jcm12185979.


Compensatory Transition of Bile Acid Metabolism from Fecal Disposition of Secondary Bile Acids to Urinary Excretion of Primary Bile Acids Underlies Rifampicin-Induced Cholestasis in Beagle Dogs.

Gui L, Wu Q, Hu Y, Zeng W, Tan X, Zhu P ACS Pharmacol Transl Sci. 2021; 4(2):1001-1013.

PMID: 33860216 PMC: 8033783. DOI: 10.1021/acsptsci.1c00052.


Cholestasis-Associated Pruritus and Its Pruritogens.

Langedijk J, Beuers U, Oude Elferink R Front Med (Lausanne). 2021; 8:639674.

PMID: 33791327 PMC: 8006388. DOI: 10.3389/fmed.2021.639674.


Alagille Syndrome: Diagnostic Challenges and Advances in Management.

Ayoub M, Kamath B Diagnostics (Basel). 2020; 10(11).

PMID: 33172025 PMC: 7694636. DOI: 10.3390/diagnostics10110907.